51YunJian
The AI engine Fit Assessment
BetaYunjian leverages machine learning and big data to discover disease markers and expand therapeutics, demonstrating a strong fit for the requirements.
Blurb
Yunjian is a metabolomics- and protein-based marker-finding technology.
HQ Location
Shanghai (China)
Founded
2015
Employees
11 - 50
Total funding raised
$1.29M
Last Funding Event
Series B, August 19, 2022
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Biomarker Identification
Developer of a platform based on protein and metabolomic marker discovery technologies. The company focuses on applying innovative multi-omics and artificial intelligence technologies to the screening, diagnosis and treatment of diseases, providing clients with products and services such as early screening of chronic diseases and cancer, medication guidance, recurrence monitoring, and new tumor drug research and development.